Recombinant Human VEGF Receptor-Fc Fusion Protein
KHSWKH902005
Phase 3 mab completed
Quick answer
Recombinant Human VEGF Receptor-Fc Fusion Protein for Neovascular Age-related Macular Degeneration is a Phase 3 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Neovascular Age-related Macular Degeneration
- Phase
- Phase 3
- Modality
- mab
- Status
- completed